Stay updated on BGB324 with Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BGB324 with Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Melanoma and MedlinePlus Genetics were added to the page's related topics, and the revision tag was updated from v3.6.5 to v3.6.6, indicating a small metadata update.
    Difference
    0.2%
    Check dated 2026-08-30T22:38:50.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Removed the 'Melanoma' condition label from the study overview and deleted the 'related topics' header along with the MedlinePlus Genetics link in the related topics section.
    Difference
    0.2%
    Check dated 2026-08-23T19:54:01.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Added Melanoma and related topics: MedlinePlus Genetics to the related topics section. This links melanoma-related and genetics resources to the page for readers seeking additional context.
    Difference
    0.2%
    Check dated 2026-08-16T16:28:10.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.5, and items under related topics were removed (Melanoma and MedlinePlus Genetics).
    Difference
    0.2%
    Check dated 2026-08-09T12:25:55.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page's revision indicator changed from v3.6.3 to v3.6.4, signaling a new build of the study details page. This is a metadata-level update and does not modify the study information or user workflow.
    Difference
    0.1%
    Check dated 2026-07-26T00:02:39.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page's related topics section gained entries for Melanoma and MedlinePlus Genetics, expanding access to disease context and genetics resources.
    Difference
    0.2%
    Check dated 2026-07-18T20:38:51.000Z thumbnail image

Stay in the know with updates to BGB324 with Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BGB324 with Pembrolizumab in Melanoma Clinical Trial page.